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1. Introduction  
The chapter begins with a brief overview of HIV/AIDS. Different oral manifestations of 
HIV/AIDS are reported with the fact that the oral lesions parallel the decline in the number 
of CD4 cells and an increase in viral load. The chapter also presents a trend of occurrence of 
oral manifestations before ARV and during ARV era. Moreover, the impact of HIV/AIDS on 
oral health of the people living with HIV/AIDS (PLWHA) in socially disadvantaged 
communities particularly in those living in Sub Saharan Africa where majority of HIV 
positive individuals reside is discussed. In addition, a need for a balanced diet by PLWHA 
is specified and a narration of functional impairment due to HIV/AIDS related oral 
conditions which often render these people unable to eat properly is presented. Knowledge 
of Oral manifestations of HIV/AIDS among dental practitioners, medical practitioners and 
people living with HIV/AIDS as well as the influence of this knowledge to the care for 
PLWHA is explored. A brief description of the care expectations of PLWHA from the 
medical and dental personnel is sighted. Eventually, recommendations for possible 
interventions are provided. 
2. Overview of HIV/AIDS 
Human immunodeficiency virus (HIV) is a lentivirus, a member of the retrovirus family that 
causes Acquired Immunodeficiency Syndrome or AIDS (Douek et al., 2009), an infectious 
disease in humans, in which progressive failure of the immune system allows life-
threatening opportunistic infections and various cancers to thrive. HIV infection in humans 
is considered pandemic by the World Health Organization (WHO). HIV has been shown to 
have infected about 0.6% of the world's population and since its discovery in 1981 to the 
year 2006 AIDS has killed more than 25 million people. In 2009, AIDS claimed an estimated 
1.8 million lives, down from a global peak of 2.1 million in 2004. However, a peak of an 
estimated 2.6 million people were newly infected in 2009 (UNAIDS report 2010). A 
disproportionate number of AIDS deaths occur in Sub-Saharan Africa, retarding economic 
growth and exacerbating the burden of poverty (Greener, 2002). UNAIDS report that Sub-
Saharan Africa remains by far the worst-affected region, with an estimated 22.5 million 
people currently living with HIV/AIDS (67% of the global total), 1.3 million deaths (72% of 
the global total) and 1.8 million new infections (69% of the global total). However, the 
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number of new infections declined by 19% across the region between 2001 and 2009, and by 
more than 25% in 22 sub-Saharan African countries during this period (UNAIDS report 2010). 
2.1 Types of HIV, virulence and mode of attack 
Two types of HIV have been characterized: HIV-1 and HIV-2. HIV-1 is the virus that was 
initially discovered and termed both LAV and HTLV-III. It is more virulent, more infective 
and is the cause of the majority of HIV infections globally (Centers for Disease Control and 
Prevention 2001, Gilbert, et al., 2003). The lower infectivity of HIV-2 compared to HIV-1 
implies that fewer of those exposed to HIV-2 will be infected per exposure. Because of its 
relatively poor capacity for transmission, HIV-2 is largely confined to West Africa (Reeves 
and Doms, 2002). The HIV is a frequently mutating retrovirus.  
HIV infection has 3 stages; acute infection or primary infection stage, latency stage and 
AIDS. The acute infection lasts for several weeks and may include symptoms such as fever, 
lymphadenopathy that is swollen lymph nodes, pharyngitis presenting as sore throat, rash, 
muscle pain (myalgia), malaise and mouth and esophageal sore. During this stage most oral 
manifestations occur and these have been shown to be indicators for counseling and testing 
(Fabian et al., 2009). The latency stage is the second stage and it involves few or no 
symptoms and can last anywhere from two weeks to twenty years or more depending on 
the individual. AIDS, is the final stage of HIV infection, and is defined by low CD4+ T cell 
counts (fewer than 200 per microliter), presence of various opportunistic infections such as 
various parasitic, viral and microbial infections, cancers and other conditions. A small 
percentage of HIV-1 infected individuals retain high levels of CD4+ T-cells without being on 
antiretroviral therapy. However, most have detectable viral load and will eventually 
progress to AIDS without treatment, albeit more slowly than others. These individuals are 
classified as HIV controllers or long-term non-progressors (LTNP). People who maintain 
CD4+ T cell counts and also have low or clinically undetectable viral load without anti-
retroviral treatment have also been given the name of elite controllers or elite suppressors 
(ES) (Blankson, 2010; Grabar et al., 2009). 
2.2 Testing for HIV  
The first and most common blood test for patients who are suspected of having HIV 
infection, is usually the enzyme-linked immunosorbent assay (ELISA) test for the presence 
of HIV antibody in their blood. HIV-1 testing consists of initial screening with the ELISA to 
detect antibodies to HIV-1. Specimens with a nonreactive result from the initial ELISA are 
considered HIV-negative. Specimens with a reactive ELISA result are retested in duplicate 
(Piatak, et al., 1993). If the result of either duplicate test is reactive, the specimen is reported 
as repeatedly reactive and undergoes confirmatory testing with a more specific 
supplemental test such as the Western blot or, less commonly, an immunofluorescence assay 
(IFA). Only specimens that are repeatedly reactive by ELISA and positive by IFA or reactive 
by Western blot are considered HIV-positive and indicative of HIV infection. Specimens that 
are repeatedly ELISA-reactive occasionally provide an indeterminate Western blot result, 
which may be either an incomplete antibody response to HIV in an infected person or 
nonspecific reactions in an uninfected person. The combination of the ELISA and Western 
blot tests is more than 99.9% accurate in detecting HIV infection within four to eight weeks 
following exposure. The polymerase chain reaction (PCR) test can be used to detect the 
presence of viral nucleic acids in the very small number of HIV patients who have false-
negative results on the ELISA and Western blot tests. These tests are also used to detect 
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viruses and bacteria other than HIV and AIDS. In socially disadvantaged communities 
however, these procedures of testing may not be feasible due to social constraints 
specifically poor social economic environments. This is where the oral manifestations 
become important indicators and most probably testing may depend only on ELISA test and 
CD4 level counts. 
3. Oral manifestations of HIV infection 
Over 30 different oral manifestations of HIV disease have been reported since the beginning 
of the AIDS epidemic (Schiødt & Pindborg, 1987). Several groups of these oral 
manifestations are known. They may be; infections, neoplasms or other manifestations. 
Infections include fungal, viral or bacterial. Whereas, the most common neoplasms are 
Kaposi’s Sarcoma and Non-Hodgkin’s Lymphoma. The others category include non-specific 
or Aphthous-like ulcers, idiopathic thrombocytopenic purpura, mucosal melanin 
pigmentation and salivary gland diseases. 
3.1 Fungal infections 
Fungal infection or Oral Candidiasis (broadly known as thrush) is a relatively frequent 
problem for people who are HIV positive. People with candidiasis often notice changes in 
taste perception, which may make food undesirable. Oral candidiasis has been described to 
occur during the acute stage of HIV infection, (Dull et al., 1991) but it occurs most 
commonly with falling CD4+ T-cell count in the middle and late stages of HIV disease. 
Several reports indicate that most persons with HIV infection carry a single strain of 
Candida during clinically apparent candidiasis and when candidiasis is quiescent (Miyasaki et 
al., 1992). Oral Candidiasis may present in either of the following forms; pseudomembranous 
candidiasis, erythematous candidiasis, hyperplastic candidiasis, or angular cheilitis. 
3.1.1 Pseudomembranous candidiasis 
Pseudomembranous candidiasis is by far the most common form of oral candidiasis. 
Pseudomembranous candidiasis appears as a white “curd-like” material (Fig. 1) that when 
wiped off reveals an underlying erythematous mucosa (Shiboski et al., 2009). Removable 
plaques on the oral mucosa are caused by overgrowth of fungal hyphae mixed with 
desquamated epithelium and inflammatory cells. This type of candidiasis may involve any 




Fig. 1. Pseudomembranous candidiasis on the palate (a courtesy of F. Kahabuka) 
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3.1.2 Erythematous candidiasis 
Erythematous candidiasis appears as flat, red patches of varying size (Fig. 2). It commonly 
occurs on the palate and the dorsal surface of the tongue (Shiboski et al., 2009). 
Erythematous candidiasis is frequently subtle in appearance and clinicians may easily 
overlook the lesions, which may persist for several weeks if untreated. Identification of 
fungal hyphae in the lesion is necessary to make a definitive diagnosis. Both Erythematous 
candidiasis and Pseudomembranous candidiasis can cause changes in taste perception 
and/or pain and a burning sensation. 
 
 
Fig. 2. Erythematous candidiasis on the palate (a courtesy of F. Kahabuka) 
3.1.3 Hyperplastic candidiasis 
This type of candidiasis is unusual in persons with HIV infection. The lesions appear white 
and hyperplastic. The white areas are due to hyperkeratosis and, unlike the plaques of 
pseudomembranous candidiasis, hyperplastic candidiasis cannot be removed by scraping. The 
lesions may be confused with hairy leukoplakia. Diagnosis of hyperplastic candidiasis is made 
from the histologic appearance of hyperkeratosis and the presence of hyphae in the lesion.  
3.1.4 Angular cheilitis 
Angula cheilitis appears as an erythema and/or fissuring either unilaterally or bilaterally at 
the corners of the mouth (Shiboski et al., 2009). It can appear alone or in conjunction with 
another form of intraoral candidiasis. This condition is easily mistaken for chapped lips. 
3.2 Viral infections 
Members of the human herpesvirus (HHV) and human papillomavirus (HPV) families are the 
most common causes of primary viral infections of the oral cavity. Nonetheless, many other 
viral infections can affect the oral cavity in humans, either as localized or systemic infections. 
3.2.1 Herpes simplex 
Oral herpes simplex is a viral condition associated with herpes simplex virus type 1 (HSV-
1). It is characterized by the eruption of serum-filled vesicles, or blisters (sometimes referred 
to as "cold sores" or "fever blisters") on the face, lips, or mouth. Herpes simplex lesions may 
be large, painful, and more prone to secondary infection in HIV-positive individuals. These 
lesions can cause pain and decrease the ability to eat comfortably.  
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3.2.2 Herpes zoster 
Oral herpes zoster generally causes skin lesions. Following a prodrome of pain, multiple 
vesicles appear on the facial skin, lips, and oral mucosa. Skin and oral lesions are frequently 
unilateral and follow the distribution of the maxillary and/or mandibular branches of the 
trigeminal nerve. The skin lesions form crusts and the oral lesions coalesce to form large 
ulcers. The ulcers frequently affect the gingiva, so tooth pain may be an early complaint. The 
reactivation of varicella zoster virus (VZV) causes herpes zoster (shingles). The disease 
occurs in the elderly and the immunosuppressed. 
3.2.3 Human Papillomavirus (HPV) lesions  
HPV-associated lesions frequently occur in the oral cavity, including the lip and sides of the 
tongue. HPV lesions in the oral cavity may appear as solitary exophytic, papillary or 
multiple nodules. They may be sessile or pedunculated and appear as multiple, smooth-
surfaced raised masses resembling focal epithelial hyperplasia or as multiple, small 
papilliferous or cauliflower-like projections. Lesions caused by HPV are common on the 
skin and mucous membranes of persons with HIV disease. HPV lesions tend to be more 
serious and more difficult to treat in HIV-positive people. A few reports also suggest that 
these oral lesions may be more prevalent, or the number of lesions may be greater in people 
with HIV. 
3.2.4 Cytomegalovirus  
Oral ulcers caused by cytomegalovirus (CMV) have been reported (Jones et al., 1993). These 
ulcers can appear on any mucosal surface and may be confused with aphthous ulcers 
(Heinic et al., 1993), necrotizing ulcerative periodontitis (NUP), (Dodd et al., 1993), and 
lymphoma. Unlike aphthous ulcers, however, which usually have an erythematous margin, 
CMV ulcers appear necrotic with a white halo, (Langford et al., 1990). Diagnosis of CMV 
ulcers is made from a biopsy but immunohistochemistry may be helpful.  
3.2.5 Hairy Leukoplakia and Epstein-Barr virus  
Oral hairy leukoplakia (HL), which presents as a nonmovable, corrugated or "hairy" white 
lesion on the lateral margins of the tongue, occurs in all risk groups for HIV infections, 
although less commonly in children than in adults, (Nadal et al., 1992). HL occurs in about 
20% of persons with asymptomatic HIV infection and becomes more common as the CD4+ 
T-cell count falls, (Feigal et al 1991). HL lesions vary in size and appearance and may be 
unilateral or bilateral. The surface is irregular and may have prominent folds or projections, 
sometimes markedly resembling hairs. Occasionally, however, some areas may be smooth 
and flat. Lesions occur most commonly on the lateral margins of the tongue and may spread 
to cover the entire dorsal surface. While this condition may resemble thrush, hairy 
leukoplakia lesions cannot be wiped off, unlike the lesions of thrush. Hairy leukoplakia is 
thought to be caused by the Epstein-Barr virus (Frezzini et al., 2006). It is also associated 
with infectious mononucleosis. Since this condition is rarely seen unless the CD4 cell count 
is low, it is less common in areas where combination anti-HIV therapy is readily available. A 
definitive diagnosis requires identification of Epstein-Barr virus infected epithelial cells. 
3.3 Bacterial infections 
The most common oral lesions associated with bacterial infection are periodontal diseases. 
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3.3.1 Periodontal disease  
Periodontal disease is a fairly common problem in both asymptomatic and symptomatic 
HIV-infected patients, (Masouredis  et al., 1992, Winkler  et al., 1992). It can take two forms: 
the rapid and severe condition called necrotizing ulcerative periodontitis (NUP), (Glick et 
al., 1994) and its associated and possibly precursor condition called linear gingival erythema 
(LGE), (Grbic et al., 1995). The presenting clinical features of these diseases often differ from 
those in non-HIV-infected persons in that unlike for non-HIV-related periodontal disease 
LGE and NUP often occur in clean mouths where there is very little plaque or calculus to 
account for the gingivitis.  
3.3.2 Linear Gingival Erythema 
The gingival (gum) condition originally known as HIV-gingivitis, and now called linear 
gingival erythema (LGE), appear as a distinct band of erythema of the gingival margin that 
does not respond to removal of local factors. LGE may be painful may bleed and may 
progress to periodontal disease. Sometimes LGE may be mistaken for ordinary gingivitis 
which usually is not painful and does not lead to periodontal disease.  
3.3.3 Necrotizing Ulcerative Periodontal disease 
Necrotizing ulcerative periodontitis (NUP), which previously was called HIV-periodontitis, 
is a condition associated with rapid soft tissue and bone loss, including exposure of the 
bone; rapid deterioration of tooth attachment; and the premature loss of teeth. Periodontal 
disease may go unnoticed until the tissues supporting the teeth are so damaged as to cause 
the loss of a tooth.  
3.4 Neoplasms 
Several opportunistic tumors (cancers or neoplasms) are associated with HIV infection. Two 
of them namely; Kaposi’s sarcoma (KS) and non-Hodgkin’s Lymphoma (NHL) occur most 
frequently and may manifest in the oral cavity. Both of these conditions are seen when 
immune suppression is severe and an individual has an AIDS diagnosis (a CD4 cell count 
below 200 cells/mm3).  
3.4.1 Kaposi's Sarcoma 
Kaposi's sarcoma (KS) is the most common neoplasm in people with HIV. KS may occur 
intraorally, either alone or in association with skin and disseminated lesions, (Ficarra et al 
1988). Intraoral lesions have been reported at other sites and may be the first manifestation 
of late-stage HIV disease (AIDS). 
KS can appear as a red, blue, or purplish lesion that do not blanch (whiten) with pressure. It 
may be flat or raised, solitary or multiple. Lesions’ size ranges from small to extensive, often 
they enlarge rapidly and may become exophytic (grow outward). The most common oral 
site is the hard palate (Shiboski et al., 2009), but lesions may occur on any part of the oral 
mucosa, including the gingiva, soft palate, buccal mucosa and in the oropharynx, (Fig 3). 
Occasionally, yellowish mucosa surrounds the KS lesion. Oral KS lesions may enlarge, 
ulcerate, and become infected. Good oral hygiene is essential to minimize these 
complications. Biopsy and histologic examination are important in order to make a 
definitive diagnosis.  
www.intechopen.com
 




Fig. 3. Kaposi’s sarcoma on the palate and skin (a courtesy of O. Hamza) 
3.4.2 Non-Hodgkin's lymphoma 
Diffuse, undifferentiated non-Hodgkin's lymphoma (NHL) is a frequent HIV-associated 
malignancy. NHL is the second most common tumor associated with HIV/AIDS (Frezzini et 
al., 2006), it can occur anywhere in the oral cavity.  Most often NHL occurs as a soft, tumor-
like mass (with or without involvement of underlying bone) that may enlarge rapidly. The 
lesion may present as firm, painless swelling that may be ulcerated but may also appear as 
necrotic or nonulcerated masses. Oral NHL may be confused with major aphthous ulcers 
and rarely as a pericoronitis associated with an erupting third molar. Histologic examination 
of biopsy specimens is required in order to make a definite diagnosis of NHL. 
4. Other oral lesions associated with HIV disease 
4.1 Oral ulceration 
Oral ulcers resembling recurrent aphthous ulcers (RAUs) in HIV-infected persons are 
reported with increasing frequency. The cause of these ulcers is unknown. Proposed causes 
include stress and unidentified infectious agents. In HIV-infected patients, the ulcers are 
well circumscribed with erythematous margins. The ulcers of the minor RAU type may 
appear as solitary lesions of about 0.5 to 1.0 cm. The herpetiform type appears as clusters of 
small ulcers (1 to 2 mm), usually on the soft palate and oropharynx. The major RAU type 
appears as extremely large (2 to 4 cm) necrotic ulcers. The major RAUs are very painful and 
may persist for several weeks. The ulcers usually occur on nonkeratinized mucosa; this 
characteristic differentiates them from those caused by herpes simplex. 
4.2 Aphthous stomatitis 
Aphthous stomatitis (canker sores) is a common condition regardless of HIV status. In HIV-
positive individuals the ulcers or sores may be slow to heal, and aphthous ulcers minor are 
more likely to become aphthous ulcers major.  
4.3 Idiopathic Thrombocytopenic Purpura 
Idiopathic thrombocytopenic purpura (ITP) has been reported to occur in HIV-infected 
patients. Oral lesions may be the first manifestation of this condition. They may present as 
petechiae, ecchymoses and hematoma anywhere on the oral mucosa. Spontaneous bleeding 
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from the gingiva can occur, and patients may report finding blood in their mouths on 
waking up. 
4.4 Salivary Gland Disease and Xerostomia 
Bilateral parotid gland enlargement occurs in HIV infected individuals. Salivary gland 
disease associated with HIV infection (HIV-SGD) can present as xerostomia with or without 
salivary gland enlargement. Salivary gland enlargement in children and adults with HIV 
infection usually involves the parotid gland (Fig 4). The enlarged salivary glands are soft but 
not fluctuant. The enlarged parotid glands can be a source of annoyance and discomfort. 
HIV-infected patients may also experience dry mouth in association with taking certain 
medications (such as ddI, antidepressants, antihistamines, and antianxiety drugs) that can 
hinder salivary secretion.  
 
 
Fig. 4. Unilateral Parotid gland enlargement (a courtesy of F. Kahabuka) 
4.5 Mucosal melanin pigmentation 
Single and multiple oral mucosal melanotic macules have been reported to occur in HIV 
infected individuals. Some have been associated with zidovudine therapy. Their significance 
is not known and thus no treatment is indicated.  
5. The relationship of HIV and oral health  
Essentially, oral manifestations of HIV/AIDS are opportunistic diseases or manifestations of 
immune deficiency or derangement. They are not caused directly by HIV and in fact the 
same lesions occur in association with other immune deficiency disorders. Most oral health 
problems can be found in people who are either HIV positive or negative. But there are 
some differences worthy noting. Some conditions are found more often in PLWHA than the 
normal population. These include Oral candidiasis, Aphthous stomatitis (canker sores) and 
herpes simplex. Few oral health conditions are seen almost exclusively in people living with 
HIV/AIDS which include Oral Hairy Leukoplakia and opportunistic tumors, while some 
that are found in both populations are more problematic for people with HIV, especially 
those with advanced disease. Regarding dental caries, it is known that some medications 
used by people living with HIV/AIDS and even HIV itself may cause decreased salivary 
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flow, or dry mouth, which is known to contribute to rampant caries. This type of caries 
frequently develops at the cervical region of the tooth, and the cervical area is more likely to 
decay at a faster rate. While periodontal diseases can occur in anyone regardless of his/her 
HIV status, one particularly severe form (necrotizing ulcerative periodontitis) and a related 
condition (linear gingival erythema) appear to be unique to those with compromised 
immune systems. Many of the earliest manifestations of the immune suppression associated 
with HIV infection occur in the mouth – particularly oral candidiasis, but also viral and 
sometimes severe bacterial infections, including tuberculosis. The presence of these lesions 
may be an early diagnostic indicator of immunodeficiency and HIV infection, may change 
the classification of the stage of HIV infection, and is a predictor of the progression of HIV 
disease (Lifson et al., 1994). The dental and oral health professions therefore have a key role 
in early diagnosis, and in the management of these distressing infections. 
6. Trend of occurrence of oral manifestations before ARV and during ARV era 
Oral manifestations of HIV infection are a fundamental component of disease progression 
with up to 90% of HIV-seropositive patients developing oral lesions through the course of 
their HIV-infection (Arendorf et al., 1998, Dios et al., 2000, Patton et al., 2000, Samaranayake 
et al., 2002). Occurrence of the oral lesions parallels the decline in the number of CD4 cells 
counts less than 200 cells/mm3, and an increase in viral load greater than 3000 copies/mL, 
xerostomia, poor oral hygiene and smoking, (Aquirre et al., 1999, Tappuni & Fleming, 2001). 
Oral lesions are thus independent indicators of the HIV disease progression.  
Following the introduction of highly active antiretroviral therapy (HAART), the oral 
manifestations of human immunodeficiency virus infection has changed drastically, 
(Aguirre et al., 1999, Domaneschi et al., 2011, Johnson 1999, Patton et al., 2000). HAART is 
effective in suppressing plasma-HIV viral load below a detectable level and elevating CD4 
cell counts. One study noted a reduction of oral lesions from 47.6% pre-HAART to 37.5% 
during the HAART era (Patton et al., 2000). The study further reported a significant 
reduction in oral hairy leukoplakia and necrotizing ulcerative periodontitis, but on the other 
hand found no significant change in the incidence of oral candidiasis, oral ulcers and Kaposi’s 
sarcoma. However, an increase was observed to occur in the HAART era of the salivary gland 
disease (Patton et al., 2000), and of oral warts (Greenspan et al., 2001, King et al., 2002). 
Reports from few countries in the Sub Saharan Africa present a closely similar picture. In 
Tanzania Hamza et al., (2006) observed oral lesions in 39.5% of the patients whereas Fabian 
et al., (2009) reported at least one oral lesion in 45% of the PLWHA they examined while 
Mwangosi & Majenge, (2011) reported a prevalence of oral manifestations to be 23.5%. In 
Kenya Butt et al., (2001) reported over 80% prevalence of candidiasis of the hyperplastic, 
erythematous and pseudomembraneous types, 27.9% prevalence of lymphadenopathy and 
angular cheilitis, while oral Kaposi's sarcoma was seen in 13% of the patients. Six years later, 
Butt et al., (2007) encountered oral manifestations with highest prevalence in the oral cavity 
to include: angular cheilitis 32.4%, hyperplastic candidosis (labial mucosa) 15%, 
erythematous candidosis (gingival) 5%, Kaposis sarcoma (hard/soft palate) 2.9% and 
Parotid enlargement 2%. Shiboski (2002) in South Africa reported that oral candidiasis (OC) 
was the most common oral lesion among HIV-infected women, and that the preliminary 
findings suggest that HAART is associated with a decreasing OC incidence. A study by 
Rwenyonyi et al., (2011) among Ugandan children living with HIV/AIDS recorded one or 
more oral lesions in 73% of the children examined. Furthermore, they found cervical 
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lymphadenopathy (60.8%), oral candidiasis (28.3%) and gingivitis (19.0%) to be the most 
common soft tissue oral lesions. They reported that the overall frequency distribution of soft 
tissue oral lesions was significantly lower in children on highly active antiretroviral therapy 
(HAART) as compared to their counterparts not on HAART. 
7. Knowledge of oral manifestations of HIV/AIDS, infection control and dental 
care services to people living with HIV and AIDS 
7.1 Knowledge of oral manifestations 
Dental practitioners have satisfactory knowledge about HIV and AIDS as well as oral 
manifestations of HIV/AIDS. Dental students alike, especially in the last years of training 
have sufficient knowledge on HIV and AIDS. The attitude of dental practitioners and dental 
students towards HIV positive patients is good. Majority are willing to give dental 
treatment to HIV positive patients (Arjuna et al., 2011, Park et al., 2011, Turhan et al., 2010), 
though a few never treat HIV positive patients (McQuistan et al., 2010). In relation to HIV 
transmission, some dental students and even some dental personnel believe that HIV can be 
easily transmitted during clinical procedures. Some dentists, dental students and some 
dental school deans prefer that HIV/AIDS patients should be referred to specialized clinics 
(Ryalat et al., 2011, Vázquez-Mayoral et al., 2009). On the other hand, medical practitioners' 
knowledge of oral manifestations of HIV/AIDS is insufficient. Likewise people living with 
HIV/AIDS have limited awareness of oral manifestations of HIV/AIDS (Kahabuka et al., 
2007). The limited knowledge and awareness may negatively impact oral health care 
delivery to the PLWA but may also limit utilization of dental care services even when they 
are available (Pereyra et al., 2011). 
7.2 Knowledge on infection control measures 
During provision of oral health care services, it is imperative to adhere to infection control to 
prevent transmission of diseases from patient to healthcare worker, healthcare worker to 
patient and patient to patient. Indeed, to be able to control cross infection of any blood borne 
diseases, the highest standards of infection control must be maintained in all clinical 
situations. This is essential in as far as controlling HIV spread is concern. Despite the 
importance of infection control in dental practice, a study by Uti et al., (2009) showed that 
while the level of knowledge of the dentists was generally acceptable, there was still partial 
compliance with recommended infection control procedures among Nigerian dentists as a 
result of inadequate supplies. Therefore, dental students and dental personnel must be 
provided with proper and current education on infection control as well as sufficient 
supplies in order to enhance positive attitude towards HIV positive patients. In the event a 
dental personnel or dental student finds himself/herself HIV positive appropriate action 
should be taken to protect patients and staff.   
7.3 Dental care services to PLWHA 
In socially disadvantaged communities, it is common to find people living with unmet 
dental care needs (Kikwilu et al., 2008). For people living with HIV/AIDS oral 
manifestations add to an already existing problem of unmet dental care needs. A number of 
factors contribute to this situation. Some of them are; high cost, unavailability of the 
services, lack of insurance and education, a shortage of dentists trained or willing to treat 
persons living with HIV/AIDS, patient fear and discomfort with dentists, stigma within 
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health care systems, lack of awareness of the importance of regular dental care, and other 
competing priorities, (Mofidi & Gambrell, 2009, McQuistan et al., 2010). Like any health 
condition faced by HIV-positive people, early identification and treatment should be 
emphasized. In many cases, when PLWHA are attended by medical professionals for other 
ailments referral to a dentist should be made as soon as possible for management of oral 
lesions. The dental profession therefore, has an obligation to provide the required dental 
services to PLWHA. 
8. Need for a balanced diet by people living with HIV/AIDS (PLWHA)  
Food is the foundation of nutritional health. Nothing can replace food. It can be 
supplemented, adjusted, increased or decreased, but not entirely replaced. Food provides 
the building blocks of carbohydrates, proteins and fats (the macronutrients), as well as 
vitamins and minerals, (the micronutrients). The best way to make sure an individual gets 
all of these nutrients is by eating a wide variety of healthy foods every day (Centre for 
Disease Control 1987). Unfortunately during the acute stage, PLWHA develop oral 
manifestations most of which are painful conditions that may impair eating. Disturbances in 
eating hinders accomplishment of the PLWHA’s need for a nutritionally balanced diet 
required much more than uninfected individuals because they need to naturally boost their 
immune system but also they need to deal with the weight loss. Moreover, AIDS is well 
known for causing severe weight loss known as wasting (WHO 2005). Whereas starving 
people tend to lose fat first, the weight lost during HIV infection tends to be in the form of 
lean tissue, such as muscle (WHO 2005). This type of wasting led to the term “slim” in some 
African countries during the early years of AIDS pandemic because AIDS sufferers lost a lot 
of lean tissue. In children, HIV is frequently linked to growth failure. One large European 
study found that children with HIV were on average around 7 kg (15 lbs) lighter and 7.5 cm 
(3 inches) shorter than uninfected children at ten years old (Kotler et al., 1989a). The double 
factors, that is inability to eat properly and the wasting caused by HIV infection make the 
PLWHA more vulnerable to nutritional insufficiency. 
8.1 Weight loss and mortality 
In a study done in Tanzania among people living with HIV/AIDS (Fabian et al., 2009) it was 
shown that the mean BMI in males was 21.01 ± 3.89 (SD) and in females the figure was 22.81 
± 3.85 (SD). In all, low BMI was significantly correlated with presence of oral candidiasis, 
angular cheilitis, lymph node enlargement, and oral ulcers. Moreover, candidiasis was 
associated with angular cheilitis and oral hairy leukoplakia, and dry mouth was related to 
lymph node enlargement and oral hairy leukoplakia. It is therefore assumed that people 
living with HIV/AIDS cannot eat well once they have oral lesions. The U.S. Centers for 
Disease Control and Prevention (CDC) recognized wasting as an AIDS-defining condition in 
1987. The "wasting syndrome" is defined as a weight loss of at least 10% in the presence of 
diarrhea or chronic weakness and documented fever for at least 30 days that is not 
attributable to a concurrent condition other than HIV infection itself (Centre for Disease 
Control 1987). In practice, any involuntary weight loss of that magnitude is typically 
considered wasting.  
A significant relationship between weight loss and mortality, disease progression, or both 
has been demonstrated in numerous prospective and retrospective studies both before the 
advent of effective antiretroviral therapy (ART) (Guenter, P. et al., 1993, Newell et al., 2003, 
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Wheeler et al., 1998  WHO 2005) and in the current era of treatment, in regions where such 
therapy is available, (Schwenk et al., 2000, Thiebaut et al., 2000). In addition to weight loss, 
depleted levels of body cell mass, which contains the metabolically active tissue, have been 
associated with increased risk of mortality in patients with HIV infection, (Guenter, P. et al., 
1993). In socially disadvantaged communities, nutrition may become a major concern and 
probably the high mortality rate in Sub Saharan Africa may be contributed to, by poor 
nutrition. 
Increased resting energy expenditure (REE) is a common finding in patients with HIV 
infection particularly in those with systemic secondary infections, (Heijligenberg et al., 1997, 
Shevitz et al., 1999). In addition, decreased energy intake has been found to be the primary 
contributor to wasting, particularly during periods of rapid weight loss rather than REE. 
Elevated REE may serve as a cofactor in accelerating weight loss and provides evidence of a 
failure to compensate for decreased energy intake. Studies using stable isotope techniques 
have demonstrated that total energy expenditure (TEE) is not significantly elevated in 
weight-stable patients with HIV infection, when compared with estimates of TEE in other 
studies of healthy adults (Heijligenberg et al., 1997). Patients losing weight have been found 
to have decreased levels of TEE, despite elevated rates of REE, reflecting a decrease in 
physical activity levels. 
8.2 Treatment to reduce wasting 
Intervention for wasting is important in the management of people living with HIV/AIDS. 
Treatment of secondary infections and other complications of HIV infection is an important 
factor in the management of wasting, as first evidenced by an increase in weight and body 
cell mass in patients with disseminated CMV infection treated with ganciclovir, (Kotler et 
al., 1989b). Opportunistic infections that interfere with swallowing such as candidiasis, 
herpes, or CMV esophagitis make the patients particularly susceptible to wasting. In 
addition to secondary infections, aphthous ulcers, chronic diarrhea, or malabsorption of any 
etiology; depression; and other contributors to anorexia should be treated.  
8.3 Nutritional intervention to reduce wasting 
Nutritional strategies to forestall or reverse wasting must work to maintain or increase 
energy intake. Patients with HIV infection can increase protein synthesis rates during 
periods of increased dietary intake, (Selberg et al 1995). However, nutritional 
supplementation alone is unlikely to fully restore weight or lean tissue in PLWHA. Dietary 
counseling is another important factor and when counseling is done by dietitians it can help 
individuals to identify target energy intake and food choices to suit individual tastes, 
practices, and tolerances. Issues such as the importance of maintaining energy intake should 
be emphasized, even during periods when eating is not pleasurable; and can give patients 
techniques for managing HIV- or medication-related symptoms such as anorexia, early 
satiety, nausea, vomiting, diarrhea, food intolerances, and oral or esophageal ulcers. Natural 
foods including homemade juices, fruits and naturally grown foods may be the most 
suitable types of foods during the periods when the HIV/AIDS complications are further 
complicated by oral and esophageal conditions. 
Increases in net daily energy intake can be achieved with the use of oral supplements, 
despite some compensatory decrease in self-selected food consumption. Such supplements 
can be very useful in individuals for whom an inability or unwillingness to prepare or 
consume meals becomes an impediment to oral intake. A variety of liquid and solid oral 
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supplements are available, including conventional preparations and specialized formulas 
for patients with specific intolerances such as fat malabsorption or lactose intolerance. 
Elemental formulas provide another option for individuals with malabsorptive disorders. 
Some studies suggest an increased benefit from special oral preparations containing specific 
amino acids and proprietary agents for PLWHA, (Clark et al., 2000, Pichard et al., 1998, 
Shabert et al., 1999). Until further data become available, the primary criteria for selection of 
a specific supplement should be tolerability and cost.  However, use of food supplements in 
socially disadvantaged communities may not be practical because of unavailability. 
As stated by the WHO (Petersen 2006) oral health professionals have a most important role 
to play in early detection of HIV/AIDS as part of their daily practice. It is needed to ensure 
that professionals do have the necessary skills but such skills may be obtained through 
systematic continuous education. In developing countries at some areas where oral health 
professionals are not available, specially trained primary health care workers may be 
instrumental in prevention of HIV/AIDS if they undertake examinations for detectable oral 
lesions. 
9. Medical and dental service expectations of PLWHA 
PLWHA have various expectations both from medical and dental personnel. For instance, 
Guenter, D. et al., (2010) reported that there are 3 forms of professional expert that PLWHA 
expect from their physicians, these included Medical/Clinical, Legal/Statutory and 
Moral/Ethical. With regard to the medical/ clinical expectations the PLWHA required 
HIV/AIDS specific knowledge and that the knowledge should be in a context of continuity 
over time and willingness to negotiate. The legal/statutory expectations included 
advocating on behalf of patients to gain access to the broader determinants of health 
determinants such as disability, housing, food and dietary supplements that PLWHA 
identified as necessary in effectively managing their illness. The PLWHA indicated that it 
was difficult to negotiate for moral authority of physicians. There is concern by the PLWHA 
that they are negatively judged, especially with regard to mode of transmission, drug use, 
sexuality and sexual practices.  The PLWHA reported that they are open to constructive 
ethical and moral guidance regarding their health if they are treated in a nonjudgmental 
way by their physicians. Regarding expectations from dental personnel, a study done in 
Tanzania reported that PLWHA indicated a social need rather than a professional need 
(Shubi et al., 2006). The majority (95%) reported that they needed the Oral Health 
Professionals to have empathy, others (85%) indicated that they need the Oral Professionals 
to observe sterility and avoid discrimination while fewer (60%) indicated that they needed 
the professionals to set a separate special clinic for PLWHA or incorporate Oral Health 
services in the already existing special clinics for PLWHA.  
10. Recommendations 
Access to ARV remains low in socially disadvantaged communities. Oral manifestations 
affect quality of life through difficulties in food testing, chewing and swallowing. There is 
therefore need for immediate oral health care and referral, prevention and treatment of oral 
diseases. Oral health promotion is needed particularly among the socially disadvantaged 
communities especially in the developing countries. This can be accomplished through 
encouraging oral health professionals and public health professionals to work together to 
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make oral health an integral component of optimum care management and introduction of 
surveillance of oral diseases associated with HIV/AIDS. 
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